Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...

The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared ...

As a lecturer and clinical instructor in vision therapy and pediatrics, it is important to have a literature base for what I am teaching. My top 10 favorite vision therapy books provide that evidence ...

The US FDA Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to review new drug application ...

Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what ...

Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...

Dr. Caldwell is an ocular disease consultant based in Johnstown, Pennsylvania. His primary focus is the diagnosis and management of anterior and posterior segment ocular disease, and he has been a ...

IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs ...

Patient quality of life has been shown to be severely impaired by the associated ocular surface symptoms, so treatment aims for symptomatic relief and prevention of further damage to the ocular ...

For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it ...

Phil Rainey, OD, MPH, FAAO, a Johnson & Johnson speaker for about 7 years, describes how new contact lens options are helping ...

As optometrists, it is our job to determine what is really driving those symptoms. Knowing when to look deeper, taking a more ...